{"disease":{"id":"stage-iii-breast-cancer-t0n2-t1n2-t2n2-t3n1-2-or-t4","name":"stage iii breast cancer t0n2 t1n2 t2n2 t3n1 2 or t4"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02751710","title":"Impact of 18F-FDG PET-CT Versus Conventional Staging in the Management of Patients Presenting With Clinical Stage III Breast Cancer","phase":"NA","overall_status":"COMPLETED","enrollment_count":369,"lead_sponsor_name":"Ontario Clinical Oncology Group (OCOG)","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}